Seres Therapeutics soared as much as 608% on Monday after the company announced positive phase 3 trial data for its drug SER-109 was de…
A biotech stock just rocketed 608% after announcing positive phase 3 trial data (MCRB)
Posted in biotech/medical
Posted in biotech/medical
Seres Therapeutics soared as much as 608% on Monday after the company announced positive phase 3 trial data for its drug SER-109 was de…